Chemistry and conformation of vitamin D molecules

• Published in: Journal of steroid biochemistry and molecular biology 1995-06, Vol.53 (1), p.603-613
• Main Authors: Okamura, William H., Midland, M.Mark, Hammond, Marion W., Abd.Rahman, Noorsaadah, Dormanen, Murray C., Nemere, Ilka, Norman, Anthony W.
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Calcitriol - chemistry; Calcitriol - physiology; Hormones. Endocrine system; Humans; Medical sciences; Molecular Structure; Pharmacology. Drug treatments; Vitamin D - chemistry; Vitamin D - physiology
• ISSN: 0960-0760; 1879-1220
• DOI: 10.1016/0960-0760(95)00107-B

1α,25-Dihydroxyvitamin D 3 (1,25) is a structurally unique steroid hormone because it not only possesses the complete 25-hydroxycholesterol side chain, but most notably, it possesses a seco-B triene structure (it lacks a B-ring and is usually depicted in a non-steroidal, extended conformation). In contrast, the classical steroid hormones possess a truncated side chain (progesterone, cortisol, and aldosterone) or no side chain (estradiol and testosterone) and they all possess the fully intact ABCD steroid rings. These structural differences render the seco-B-steroid 1,25 considerably more conformationally flexible. Since 1,25 is now known to target a myriad of tissues where specific interactions occur to produce an array of biological responses, it is of interest to determine whether different topologies of 1,25 (resulting from different conformational orientations of 1,25) are necessary to interact effectively at the different target sites. The array of biological responses include both non-genomic and genomic effects and there is considerable promise for the efficacy of 1,25 analogs as chemotherapeutic agents in a variety of human disease states. For the non-genomic calcium transport response of transcaltachia, the finding that two 6-s- cis locked analogs, 1α,25-dihydroxyprevitamin D 3 (pre-1,25) and 1α,25-dihydroxylumisterol 3 (1,25-Lumi), are equipotent to 1,25, points strongly to the involvement of the 6-s- cis conformer of 1,25 as the biologically active conformer. Since there is a continuum of easily interconvertible 6,7-single bond conformers of the seco-B ring available to 1,25, conformational minima (either local or global) may have little to do with the manner in which 1,25 is bound to receptor. For the genomic calcium transport response, and for other genomic (or non-genomic) effects, there is no clear evidence whether the steroidal (s- cis) or non-steroidal (s- trans) conformer of 1,25 is involved. In order to address this matter further, efforts are underway to evaluate other conformationally locked analogs of 1,25 which might mimic either the planar 6-s- trans-1,25 or some intermediate conformer between it and the planar-6-s- cis form.